Tag Archives: Non small cell lung cancer
Cetuximab Increases Survival in Patients with Lung Cancer with High EGFR Expression
Good news for patients with non-small-cell lung cancer (NSCLC)! If you have NSCLC, you might like to ask your oncologist to check whether you have high expression of EGFR. Patients with high EGFR expression represented about 25 percent of people … Continue reading
New Monoclonal Antibodies Increased Survival in Lung Cancer Patients
A new study showed that non-small-cell lung cancer (NSCLC) patients who have high level of Met proteins in their tumor can have their survival increase three-fold by receiving experimental antibody MetMAb in combination with erlotinib (Tarceva). In the trial, 137 previously-treated … Continue reading
Another New Cancer Drug Crizotinib Shows Improvement in Survival
It looks like a number of new drugs might become available to lung cancer patients in the near future. Results of an early-stage study suggested that nearly two-thirds of patients with late stage non-small-cell lung cancer who received the experimental … Continue reading
Yunzhi Slows Progression of Advanced Non-small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths, but most patients (over 69%) were diagnosed at advanced stages. Although polysaccharide peptides (PSP), isolated from the fungus Yunzhi (Coriolus versicolor), have been reported to have anti-tumor effects … Continue reading
Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer
Currently, no treatment exists for lung cancer patients with epidermal growth-factor receptor (EGFR) mutation who have failed tyrosine kinase inhibitors, getifinib (Iressa) or erlotinib (Tarceva). However, an investigational drug, afatinib (BIBW 2992), was recently found to increase progression-free survival and … Continue reading
Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations
Gefitinib (Iressa) is more effective than first-line therapy in improving survival without disease in patients with advanced nonsmall-cell lung cancer (NSCLC) and epidermal growth-factor receptor (EGFR) mutations. The current study was conducted in 230 patients from 43 centers in Japan, … Continue reading
Is Shark Cartilage Helpful For Cancer Patients?
Shark cartilage has been touted as a potential alternative or complementary cancer treatment for several decades. Dozens of shark cartilage products are sold as dietary supplements, but none have been studied in humans. A recently published study indicated that adding a … Continue reading
Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
Docetaxel(Taxotere) has long been considered the standard of care for second-line treatment of advanced NSCLC. However, the disadvantage of using this agent include the need to administer it with corticosteroid premedication and its toxicity profile A new study published in … Continue reading